Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Lancet, The | 2004 | 7.5K |
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | New England Journal of Medicine | 2000 | 6.9K |
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Lancet, The | 2003 | 2.1K |
Vitamin E supplementation and cardiovascular events in high-risk patients | New England Journal of Medicine | 2000 | 1.6K |
Homocysteine lowering with folic acid and B vitamins in vascular disease | New England Journal of Medicine | 2006 | 1.3K |
Basal insulin and cardiovascular and other outcomes in dysglycemia | New England Journal of Medicine | 2012 | 1.1K |
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease | New England Journal of Medicine | 2017 | 1.1K |
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study | Journal of the American College of Cardiology | 1991 | 964 |
Comparison of fondaparinux and enoxaparin in acute coronary syndromes | New England Journal of Medicine | 2006 | 922 |
A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease | Archives of Internal Medicine | 2009 | 874 |
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience | Journal of the American College of Cardiology | 2010 | 810 |
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial | JAMA - Journal of the American Medical Association | 2006 | 685 |
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia | New England Journal of Medicine | 2012 | 659 |
Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies | European Heart Journal | 2007 | 644 |
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart | Nature Clinical Practice Cardiovascular Medicine | 2005 | 638 |
Interventions for enhancing medication adherence | The Cochrane Library | 2014 | 629 |
Intertumoral Heterogeneity within Medulloblastoma Subgroups | Cancer Cell | 2017 | 511 |
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes | Anesthesiology | 2014 | 509 |
Cardiovascular risk and events in 17 low-, middle-, and high-income countries | New England Journal of Medicine | 2014 | 499 |
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy | Nature | 2014 | 434 |
The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis | British Journal of Radiology | 2012 | 418 |
Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes | Circulation | 2010 | 412 |
Ramipril and the development of diabetes | JAMA - Journal of the American Medical Association | 2001 | 390 |
Urinary sodium and potassium excretion and risk of cardiovascular events | JAMA - Journal of the American Medical Association | 2011 | 375 |
Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism | Journal of Clinical Endocrinology and Metabolism | 2007 | 369 |